Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution

References

• Huang X, Huang Q, Chen S, et al. Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis. BMC Womens Health. 2015;15:24. doi:10.1186/s12905-015-0182-525783654
   PubMed Web of Science ®Google Scholar
• Li Q, Ding Y, Zhang XY, Feng WW, Hua KQ. Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study. J Int Med Res. 2018;46(5):1855–1865. doi:10.1177/030006051775299729552942
   PubMed Web of Science ®Google Scholar
• Buggio L, Monti E, Gattei U, Dridi D, Vercellini P. Adenomyosis: fertility and obstetric outcome. A comprehensive literature review. Minerva Ginecol. 2018;70(3):295–302. doi:10.23736/S0026-4784.17.04163-629115118
   PubMed Web of Science ®Google Scholar
• Bruun MR, Arendt LH, Forman A, Ramlau-Hansen CH. Endometriosis and adenomyosis are associated with increased risk of preterm delivery and a small-for-gestational-age child: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(9):1073–1090. doi:10.1111/aogs.1336429753309
   PubMed Web of Science ®Google Scholar
• Shin YJ, Kwak DW, Chung JH, Kim MY, Lee SW, Han YJ. The risk of preterm births among pregnant women with adenomyosis. J Ultrasound Med. 2018;37(8):1937–1943. doi:10.1002/jum.1454029363150
   PubMed Web of Science ®Google Scholar
• Tamura H, Kishi H, Kitade M, et al. Complications and outcomes of pregnant women with adenomyosis in Japan. Reprod Med Biol. 2017;16(4):330–336. doi:10.1002/rmb2.1205029259486
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Kyozuka H, Fujimori K, et al. Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: a cohort study of the Japan Environment and Children’s Study. Acta Obstet Gynecol Scand. 2018 [Epub ahead of print]. doi:10.1111/aogs.13498
   Web of Science ®Google Scholar
• Cozzolino M, Basile F, Pontrelli G. Effects of adenomyosis on obstetric outcomes: a literature review. Minerva Ginecol. 2018 [Epub ahead of print]. doi:10.23736/S0026-4784.18.04318-6
   Web of Science ®Google Scholar
• Vannuccini S, Luisi S, Tosti C, Sorbi F, Petraglia F. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril. 2018;109(3):398–405. doi:10.1016/j.fertnstert.2018.01.01329566852
   PubMed Web of Science ®Google Scholar
• Neriishi K, Hirata T, Fukuda S, et al. Long-term dienogest administration in patients with symptomatic adenomyosis. J Obstet Gynaecol Res. 2018;44(8):1439–1444. doi:10.1111/jog.1367429845696
   PubMed Web of Science ®Google Scholar
• Wu J, Huang Y, Chen L, Hu J, Zou Y. Treatment of adenomyosis with subcutaneous etonogestrel implants: a clinical observational study in 17 patients. Med Sci Monit. 2018;24:6085–6092. doi:10.12659/MSM.90897930171680
   PubMed Web of Science ®Google Scholar
• de Bruijn AM, Lohle PN, Huirne JA, de Vries J, Twisk M, Hehenkamp WJ, ; . Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA trial. JMIR Res Protoc. 2018;7(3):e47. doi:10.2196/resprot.851229496654
   PubMed Web of Science ®Google Scholar
• Keung JJ, Spies JB, Caridi TM. Uterine artery embolization: a review of current concepts. Best Pract Res Clin Obstet Gynaecol. 2018;46:66–73. doi:10.1016/j.bpobgyn.2017.09.00329128204
   PubMed Web of Science ®Google Scholar
• Liang E, Brown B, Rachinsky M. A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: results in 117 women. Aust N Z J Obstet Gynaecol. 2018;58(4):454–459. doi:10.1111/ajo.1276729344938
   PubMed Web of Science ®Google Scholar
• Guo Q, Xu F, Ding Z, Li P, Wang X, Gao B. High intensity focused ultrasound treatment of adenomyosis: a comparative study. Int J Hyperthermia. 2018:1–5. [Epub ahead of print]. doi:10.1080/02656736.2018.1509238
   Web of Science ®Google Scholar
• Keserci B, Duc NM. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis. Int J Hyperthermia. 2018:1–11. [Epub ahead of print]. doi:10.1080/02656736.2018.1516301
   Web of Science ®Google Scholar
• Wang CJ, Yuen LT, Chang SD, Lee CL, Soong YK. Use of laparoscopic cytoreductive surgery to treat infertile women with localized adenomyosis. Fertil Steril. 2006;86(2):462.e5–8.467. doi:10.1016/j.fertnstert.2005.12.066
   Web of Science ®Google Scholar
• Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109(3):406–417. doi:10.1016/j.fertnstert.2018.01.03229566853
   PubMed Web of Science ®Google Scholar
• Oliveira MAP, Crispi CP Jr, Brollo LC, Crispi CP, De Wilde RL. Surgery in adenomyosis. Arch Gynecol Obstet. 2018;297(3):581–589. doi:10.1007/s00404-017-4603-629197987
   PubMed Web of Science ®Google Scholar
• Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472–487. doi:10.1016/j.fertnstert.2013.10.02524289992
   PubMed Web of Science ®Google Scholar
• Horng HC, Chen CH, Chen CY, et al. Uterine-sparing surgery for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol. 2014;53(1):3–7. doi:10.1016/j.tjog.2014.01.00124767637
   PubMed Web of Science ®Google Scholar
• Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online. 2011;22(1):94–99. doi:10.1016/j.rbmo.2010.09.01421118751
   PubMed Web of Science ®Google Scholar
• Kwack JY, Im KS, Kwon YS. Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution. J Obstet Gynaecol Res. 2018;44(7):1268–1273. doi:10.1111/jog.1365829845687
   PubMed Web of Science ®Google Scholar
• Jun-Min X, Kun-Peng Z, Yin-Kai Z, et al. A new surgical method of u-shaped myometrial excavation and modified suture approach with uterus preservation for diffuse adenomyosis. Biomed Res Int. 2018;2018:1657237. doi:10.1155/2018/165723730112362
   PubMed Web of Science ®Google Scholar
• Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007;109(6):1411–1420. doi:10.1097/01.AOG.0000265215.87717.8b17540815
   PubMed Web of Science ®Google Scholar
• Yu W, Liu G, Liu C, Zhang Z. Recurrence-associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma. Oncol Lett. 2018;16(3):3430–3438. doi:10.3892/ol.2018.908230127945
   PubMed Web of Science ®Google Scholar
• Zheng R, Zeng D, Wan TT, Guo WB, Guo Y, Liu MJ. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis. Diagn Interv Radiol. 2018;24(6):364–371. doi:10.5152/dir.2018.1747930373724
   PubMed Web of Science ®Google Scholar
• Mu Y, Hu X, He J, et al. Serum levels of vascular endothelial growth factor and cancer antigen 125 are related to the prognosis of adenomyosis patients after interventional therapy. Int J Clin Exp Med. 2015;8(6):9549–9554.26309622
   PubMed Web of Science ®Google Scholar